Procoagulant Microvesicles
Procoagulant Microvesicles - Related Videos
06:03
Isolation and Characterization of Microvesicles from Peripheral Blood
0 Views •
Cited by 74 •
2017
Extracellular vesicles present in blood have been suggested as novel biomarkers for various diseases. Here, we present a protocol for the isolation of large plasma membrane-derived microvesicles from peripheral blood samples and their subsequent analysis by conventional flow cytometry and Western Blotting.
05:49
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
0 Views •
Cited by 2 •
2024
Procoagulant platelet formation has been correlated with an increased risk of thrombosis. Presented here is a precise protocol for isolating washed platelets from human blood, intended to quantify the exposure of phosphatidylserine and microvesicle release, which are distinctive features of procoagulant platelets.
05:26
Paper-Based Preconcentration and Isolation of Microvesicles and Exosomes
0 Views •
Cited by 4 •
2020
Presented is a protocol to fabricate a paper-based device for the effective enrichment and isolation of microvesicles and exosomes.
04:37
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
0 Views •
Cited by 1 •
2025
The present protocol provides a comprehensive set of procedures necessary to analyze procoagulant platelets, which exhibit overlapping features of necrosis, apoptosis, and platelet activation.
04:56
Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
0 Views •
2023
This protocol investigates the use of extracellular vesicle (EV)-rich plasma as an indicator of the coagulative ability of EV. EV-rich plasma is obtained through a process of differential centrifugation and subsequent recalcification.
FAQs
The key change is the movement of phosphatidylserine to the outer membrane surface during vesicle formation. This exposed lipid provides a catalytic platform where coagulation enzyme complexes can assemble, thereby supporting the reactions that promote clot formation. Its location, rather than merely its presence inside the membrane, gives these particles functional significance in hemostasis and thrombosis.
Tissue factor gives some microvesicles an additional procoagulant capability beyond the catalytic membrane surface created by exposed phosphatidylserine. It can initiate thrombin generation, linking vesicle activity to an early step in coagulation. Consequently, differences in tissue factor carriage may help explain why microvesicles vary in their ability to promote clotting.
Cell activation and cellular damage can promote the release of these vesicles, while inflammation, cancer, cardiovascular disease, and tissue injury are associated with changes in their abundance and activity. These shifts matter because they can alter the procoagulant environment around blood vessels and may connect local cellular stress with broader changes in vascular biology.
Their importance extends beyond direct effects on coagulation. Because they are released from activated or damaged cells, microvesicles can participate in communication between cells while influencing the vascular environment. This combination of intercellular signaling and procoagulant activity helps researchers examine how cellular responses to injury or inflammation may affect blood vessels and clotting.
Researchers examine their abundance and activity because both can change in inflammation, cancer, cardiovascular disease, and tissue injury. A disease-associated shift may provide information about cellular activation, damage, or altered coagulation. Studying these patterns can therefore support biomarker discovery, although the relevant interpretation depends on the biological condition being investigated.
These particles identify biological processes that may be relevant to excessive clotting, including phosphatidylserine-dependent enzyme assembly and tissue factor-associated thrombin generation. Their role makes them useful targets for investigating therapies that regulate pathological clot formation. In biology and vascular research, examining the vesicles can connect molecular mechanisms with potential strategies for controlling abnormal coagulation.